NATR icon

Nature's Sunshine

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 85.7%
Negative

Neutral
GlobeNewsWire
yesterday
Nature's Sunshine Appoints Kenneth Romanzi as CEO
Mr. Romanzi Brings Extensive Leadership and Operational Experience at Prominent, Large-Scale Consumer Packaged Goods Companies and Proven Track Record of Driving Growth and Value Creation LEHI, Utah, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine”) (the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that its Board of Directors has appointed Kenneth Romanzi to succeed Terrence Moorehead as Chief Executive Officer. Mr. Romanzi will assume the role and become a member of the Nature's Sunshine Board of Directors on October 29, 2025.
Nature's Sunshine Appoints Kenneth Romanzi as CEO
Neutral
GlobeNewsWire
9 days ago
Nature's Sunshine Relaunches Revolutionary Power Line to Combat Metabolic Health Crisis
LEHI, Utah, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR), a leading natural health and wellness company that manufactures high quality herbal and nutritional products, announced the relaunch of its Power Line suite of products with the addition of the newly launched Power Balance supplement. The enhanced product line features four supplements designed to address the growing metabolic health challenges facing millions of people worldwide.
Nature's Sunshine Relaunches Revolutionary Power Line to Combat Metabolic Health Crisis
Positive
Seeking Alpha
2 months ago
Nature's Sunshine: Premium Valuation Without Moats, Sell
Nature's Sunshine is a leading U.S.-based herbal supplement manufacturer founded in 1972, operating a Multi-Level Marketing model. Nature's Sunshine (NATR) is trading at a 16.4x forward P/E, a premium compared to the peer average of 14.2x, and higher than companies like Herbalife (4.1x) and USANA (11.2x). The company's forward revenue growth of 2.8% and mixed EPS outlook do not justify the premium valuation, especially when compared to competitors like LifeVantage, which has a 26.6% CAGR EPS.
Nature's Sunshine: Premium Valuation Without Moats, Sell
Neutral
The Motley Fool
2 months ago
Nature's Sunshine (NATR) Q2 EPS Up 400%
Nature's Sunshine (NATR) Q2 EPS Up 400%
Nature's Sunshine (NATR) Q2 EPS Up 400%
Neutral
Seeking Alpha
2 months ago
Nature's Sunshine Products, Inc. (NATR) Q2 2025 Earnings Call Transcript
Nature's Sunshine Products, Inc. (NASDAQ:NATR ) Q2 2025 Earnings Conference Call July 31, 2025 5:00 PM ET Company Participants L. Shane Jones - Executive VP of Finance, CFO & Treasurer Nathan G.
Nature's Sunshine Products, Inc. (NATR) Q2 2025 Earnings Call Transcript
Neutral
GlobeNewsWire
2 months ago
Nature's Sunshine Reports Second Quarter 2025 Results
LEHI, Utah, July 31, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the second quarter ended June 30, 2025.
Nature's Sunshine Reports Second Quarter 2025 Results
Neutral
GlobeNewsWire
3 months ago
Nature's Sunshine Sets Second Quarter 2025 Conference Call for Thursday, July 31, 2025, at 5:00 p.m. ET
LEHI, Utah, July 17, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ: NATR) (Nature's Sunshine), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Thursday, July 31, 2025, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the second quarter ended June 30, 2025. The company will report its financial results in a press release prior to the conference call.
Nature's Sunshine Sets Second Quarter 2025 Conference Call for Thursday, July 31, 2025, at 5:00 p.m. ET
Neutral
GlobeNewsWire
3 months ago
Nature's Sunshine Products, Inc. Announces Pricing of Secondary Public Offering of Common Stock
LEHI, Utah, June 26, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ: NATR) (“Nature's Sunshine” or the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the pricing of an underwritten secondary public offering of up to 2,854,607 shares of its common stock to be sold by Fosun Pharma USA, Inc (the “Selling Stockholder”). The shares of common stock are being sold at a price of $12.00 per share. The offering is expected to close on June 27, 2025, subject to customary closing conditions.
Nature's Sunshine Products, Inc. Announces Pricing of Secondary Public Offering of Common Stock
Neutral
GlobeNewsWire
3 months ago
Nature's Sunshine Products, Inc. Announces Launch of Secondary Public Offering of Common Stock
LEHI, Utah, June 25, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ: NATR) (“Nature's Sunshine” or the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the launch of an underwritten secondary public offering of up to 2,854,607 shares of its common stock to be sold by Fosun Pharma USA, Inc (the “Selling Stockholder”).
Nature's Sunshine Products, Inc. Announces Launch of Secondary Public Offering of Common Stock
Neutral
GlobeNewsWire
4 months ago
Nature's Sunshine Renews Scholarship Fund with Eccles School of Business
LEHI, Utah, June 09, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR), a leading natural health and wellness company that manufactures high quality herbal and nutritional products, announced the renewal of its scholarship in partnership with the David Eccles School of Business at the University of Utah to support economically disadvantaged students in their education.
Nature's Sunshine Renews Scholarship Fund with Eccles School of Business